UnitedHealth shares turn unusual ahead of earnings

• UnitedHealth covers approximately 12-13.5% of the U.S. population with 52 million customers worldwide (90% in the U.S.), with Commercial enrollment growing 2.9% YoY and Medicare enrollment up 4.5%
• The stock trades at 17x forward earnings with free cash flow at 5.7% of enterprise value, currently 12-13% below its two-year midpoint after falling in five of the last eight earnings reports
• Implied volatility is running at 40% versus 20% realized volatility, creating opportunities for short premium strategies as options prices are expensive relative to historical stock movement

UnitedHealth Options Market Summary

Key Event: UnitedHealth Group (UNH) reports quarterly earnings on October 13, with options markets showing unusual activity and elevated pricing.

Market Dynamics:

• Implied volatility is running at twice realized volatility (40% vs. 20%), making options expensive relative to historical stock movements
• Current options prices imply a 6.5% earnings move, the second-highest implied move in nearly two years
• Stock has moved lower in 5 of the last 8 earnings reports, including two significant declines of nearly 20% in January and April 2025

Company Fundamentals:

• Covers approximately 52 million customers worldwide (90% in U.S.), representing 12-13.5% of the U.S. population
• Commercial fee-based enrollment grew 2.9% YoY (2024-2025), outpacing U.S. workforce growth of 1.4%, indicating market share gains
• Total Medicare enrollment increased 4.5%
• Headwind: ACA marketplace-driven enrollment expected to decline

Valuation:

• Trading at 17x forward earnings
• Free cash flow at 5.7% of enterprise value and 6.5% of market cap
• Stock currently 12-13% below the two-year high-low midpoint
• Current price: $377.84

Market Implications:

The elevated implied volatility creates opportunities for short premium strategies. Analysts suggest the stock isn't priced for recovery despite reasonable valuation metrics. Enrollment growth and underwriting margins remain critical for EPS expansion. The options market's pricing suggests significant uncertainty heading into earnings, reflecting recent volatile post-earnings moves.